HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical ...
HALIFAX, NS / ACCESSWIRE / August 13, 2024 / Today, MedMira Inc. (MIR:CA) (MedMira) announces it will conduct full clinical trials for its unique Multiplo ® Complete Syphilis (TP/nTP) Antibody Test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback